Hongbo Pharmaceutical funding history / development milestones

IPO上市，创业板

2022.11.01，深交所

Note: collected from public online reports, for reference only.

Talent Demand Trend Analysis More

医药

新药研发

创新药

抗癌药物

药物研发

色谱

替格瑞洛

中间体生产

中间体

多肽

原料药生产

原药

原料

制药/药业

科学研究

People who follow Hongbo Pharmaceutical also follow

Hongbo Pharmaceutical Competitors (Similar Companies)

Follow in Bulk Copy Company Names

Pharmaceutical Research Associates, Inc. (Pharmaron Beijing) Co., Ltd.

“Helping partners successfully develop new drugs, reducing R&D costs an”

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

“A renowned enterprise in China's liver disease and anti-tumor fields”

Innovent Biologics (Suzhou) Co., Ltd.

“To develop high-quality biologics that are accessible and affordable f”

Shanghai Fosun Pharmaceutical (Group) Co., Ltd.

“Promoting human health”

泓博智源（开原）药业有限公司

制药/药业医药生物实验原料药

英矽智能科技（上海）有限公司

“抗衰老及癌症治疗药物研发商”

Jiangsu Hengrui Pharmaceuticals Co., Ltd.

“Research, development, and production of anti-tumor and surgical medic”

Zhejiang Jiuzhou Pharmaceutical Co., Ltd.

“Caring for life, maintaining health”

Nanjing Sanhome Pharmaceutical Co., Ltd.

软膏剂医药工业原料药制药/药业

BioDuro Technology (Beijing) Co., Ltd.

“Focused on providing drug discovery services to biopharmaceutical clie”

AstraZeneca Investment (China) Co., Ltd.

“Global integrated biopharmaceutical enterprise”

BGI Genomics Co., Ltd.

“Gene technology benefits humanity”

Pfizer Investment Co., Ltd.

“Continuously innovating to bring patients medicines that significantly”

Nanjing PharmBlock Sciences (Nanjing) Co., Ltd.

“Innovative chemical products and services provider in the drug researc”

Asymchem Laboratories (Tianjin) Co., Ltd.

“Technological innovation and commercial application of pharmaceutical ”

中 中文版 View this page in Chinese ›